Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Zeltiq Aesthetics IPO

Zeltiq Aesthetics IPO Newsletter

Forbion taps ex-Dyne CEO Josh Brumm as general partner, plans Boston office 27 Jun 2024 18:02 GMT
… company, led Dyne through its initial public offering on the Nasdaq in 2020 … as Kaleido Biosciences, Aravive, Pharmacyclics, Zeltiq Aesthetics and Proteolix. “I am delighted … press release and heralded his IPO and fundraising work. In addition …
Forbion Strengthens US Presence, Hiring Biotech Industry Leader and Opening Boston Office 27 Jun 2024 11:00 GMT
… . He led Dyne through its initial public offering on Nasdaq in 2020, and … biotechs, including Proteolix, Pharmacyclics and ZELTIQ Aesthetics, all of which were acquired … for itself, with four Nasdaq IPOs under his belt and around …
Nautilus: This Home Fitness Company's Sales Could Be Surging During The Covid-19 Pandemic 25 Mar 2020 17:17 GMT
… behind CoolSculpting, Zeltiq Aesthetics Inc. (ZLTQ) was a busted IPO with a compelling …
Restoration Robotics® Announces Appointment of Mark Hair as Chief Financial Officer 11 Dec 2017 13:01 GMT
… and Chief Accounting Officer at ZELTIQ Aesthetics, a medical technology company focused … guide Restoration Robotics through our initial public offering which we completed in October …
UroGen Pharma Strengthens Management Team with the Appointment of Paul Chu as Vice President of Business Development 06 Sep 2017 13:12 GMT
… notably Allergan’s acquisition of Zeltiq Aesthetics, Inc. for $2.5 billion … prospectus for UroGen Pharma’s initial public offering of securities in the United …
UroGen Pharma Strengthens Management Team with the Appointment of Paul Chu as Vice President of Business Development 06 Sep 2017 12:30 GMT
… notably Allergan’s acquisition of Zeltiq Aesthetics, Inc. for $2.5 billion … prospectus for UroGen Pharma’s initial public offering of securities in the United …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS